Page last updated: 2024-09-02

procyanidin and docetaxel anhydrous

procyanidin has been researched along with docetaxel anhydrous in 2 studies

Compound Research Comparison

Studies (procyanidin)	Trials (procyanidin)	Recent Studies (post-2010) (procyanidin)	Studies (docetaxel anhydrous)	Trials (docetaxel anhydrous)	Recent Studies (post-2010) (docetaxel anhydrous)
4,116	136	2,747	12,110	3,216	6,920

Protein Interaction Comparison

Protein	Taxonomy	procyanidin (IC50)	docetaxel anhydrous (IC50)
Kinesin-like protein KIF11	Homo sapiens (human)		0.0014
Nucleotide-binding oligomerization domain-containing protein 2	Homo sapiens (human)		5.0119

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Gao, JJ; Pohlmann, PR; Swain, SM; Tan, M	1
Boso, S; Freire-Garabal, M; Gago, P; García, C; Martínez, MC; Novio, S; Núñez-Iglesias, MJ; Pérez-Muñuzuri, ME; Santiago, JL	1

Trials

1 trial(s) available for procyanidin and docetaxel anhydrous

Article	Year
HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens. Clinical breast cancer, 2017, Volume: 17, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Diarrhea; Docetaxel; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Proanthocyanidins; Prognosis; Quality of Life; Taxoids; Trastuzumab; Young Adult	2017

Article

Year

HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens.

Clinical breast cancer, 2017, Volume: 17, Issue:1

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Diarrhea; Docetaxel; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Proanthocyanidins; Prognosis; Quality of Life; Taxoids; Trastuzumab; Young Adult

2017

Other Studies

1 other study(ies) available for procyanidin and docetaxel anhydrous

Article	Year
Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In Vitro. International journal of molecular sciences, 2021, Jul-02, Volume: 22, Issue:13 Topics: Antineoplastic Agents; Biflavonoids; Breast Neoplasms; Catechin; Docetaxel; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Male; MCF-7 Cells; Proanthocyanidins; Prostatic Neoplasms	2021

Article

Year

Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In Vitro.

International journal of molecular sciences, 2021, Jul-02, Volume: 22, Issue:13

Topics: Antineoplastic Agents; Biflavonoids; Breast Neoplasms; Catechin; Docetaxel; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Male; MCF-7 Cells; Proanthocyanidins; Prostatic Neoplasms

2021